The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Mental Illness is a psychological anomaly that is reflected in patient’s behavior through disability, distress, or any conduct that is not considered as normal mental development. The causes of mental lllness are very diverse and often unclear in most cases.
The global Mental Illness Drugs market was valued at US$ 1546 million in 2023 and is anticipated to reach US$ 2277.7 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.
However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mental Illness Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Illness Drugs.
Report Scope
The Mental Illness Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mental Illness Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mental Illness Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
- Johnson and Johnson
- Pfizer
- Eli Lilly
- GlaxoSmithKline
- AstraZeneca
- Bristol-Myers Squibb
Segment by Type
- Antipsychotics
- Antidepressants
- Antianxiety (anxiolyitcs)
- Anti-seizure medications
- Stimulants
- Cognitive disorders and dementia
- Sleep disorder treatments
- Substance abuse treatments
Segment by Application
- Hospital
- Clinic
- Drugstore
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mental Illness Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mental Illness Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Mental Illness Drugs Market Overview
1.1 Product Overview and Scope of Mental Illness Drugs
1.2 Mental Illness Drugs Segment by Type
1.2.1 Global Mental Illness Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Antipsychotics
1.2.3 Antidepressants
1.2.4 Antianxiety (anxiolyitcs)
1.2.5 Anti-seizure medications
1.2.6 Stimulants
1.2.7 Cognitive disorders and dementia
1.2.8 Sleep disorder treatments
1.2.9 Substance abuse treatments
1.3 Mental Illness Drugs Segment by Application
1.3.1 Global Mental Illness Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Global Mental Illness Drugs Market Size Estimates and Forecasts
1.4.1 Global Mental Illness Drugs Revenue 2019-2030
1.4.2 Global Mental Illness Drugs Sales 2019-2030
1.4.3 Global Mental Illness Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mental Illness Drugs Market Competition by Manufacturers
2.1 Global Mental Illness Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mental Illness Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mental Illness Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Mental Illness Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mental Illness Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mental Illness Drugs, Product Type & Application
2.7 Mental Illness Drugs Market Competitive Situation and Trends
2.7.1 Mental Illness Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mental Illness Drugs Players Market Share by Revenue
2.7.3 Global Mental Illness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mental Illness Drugs Retrospective Market Scenario by Region
3.1 Global Mental Illness Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mental Illness Drugs Global Mental Illness Drugs Sales by Region: 2019-2030
3.2.1 Global Mental Illness Drugs Sales by Region: 2019-2024
3.2.2 Global Mental Illness Drugs Sales by Region: 2025-2030
3.3 Global Mental Illness Drugs Global Mental Illness Drugs Revenue by Region: 2019-2030
3.3.1 Global Mental Illness Drugs Revenue by Region: 2019-2024
3.3.2 Global Mental Illness Drugs Revenue by Region: 2025-2030
3.4 North America Mental Illness Drugs Market Facts & Figures by Country
3.4.1 North America Mental Illness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mental Illness Drugs Sales by Country (2019-2030)
3.4.3 North America Mental Illness Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mental Illness Drugs Market Facts & Figures by Country
3.5.1 Europe Mental Illness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mental Illness Drugs Sales by Country (2019-2030)
3.5.3 Europe Mental Illness Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mental Illness Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Mental Illness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mental Illness Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Mental Illness Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mental Illness Drugs Market Facts & Figures by Country
3.7.1 Latin America Mental Illness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mental Illness Drugs Sales by Country (2019-2030)
3.7.3 Latin America Mental Illness Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mental Illness Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Mental Illness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mental Illness Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mental Illness Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Mental Illness Drugs Sales by Type (2019-2030)
4.1.1 Global Mental Illness Drugs Sales by Type (2019-2024)
4.1.2 Global Mental Illness Drugs Sales by Type (2025-2030)
4.1.3 Global Mental Illness Drugs Sales Market Share by Type (2019-2030)
4.2 Global Mental Illness Drugs Revenue by Type (2019-2030)
4.2.1 Global Mental Illness Drugs Revenue by Type (2019-2024)
4.2.2 Global Mental Illness Drugs Revenue by Type (2025-2030)
4.2.3 Global Mental Illness Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Mental Illness Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mental Illness Drugs Sales by Application (2019-2030)
5.1.1 Global Mental Illness Drugs Sales by Application (2019-2024)
5.1.2 Global Mental Illness Drugs Sales by Application (2025-2030)
5.1.3 Global Mental Illness Drugs Sales Market Share by Application (2019-2030)
5.2 Global Mental Illness Drugs Revenue by Application (2019-2030)
5.2.1 Global Mental Illness Drugs Revenue by Application (2019-2024)
5.2.2 Global Mental Illness Drugs Revenue by Application (2025-2030)
5.2.3 Global Mental Illness Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Mental Illness Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson and Johnson
6.1.1 Johnson and Johnson Corporation Information
6.1.2 Johnson and Johnson Description and Business Overview
6.1.3 Johnson and Johnson Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson and Johnson Mental Illness Drugs Product Portfolio
6.1.5 Johnson and Johnson Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Mental Illness Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly Mental Illness Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Mental Illness Drugs Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Mental Illness Drugs Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-Myers Squibb Mental Illness Drugs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mental Illness Drugs Industry Chain Analysis
7.2 Mental Illness Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mental Illness Drugs Production Mode & Process
7.4 Mental Illness Drugs Sales and Marketing
7.4.1 Mental Illness Drugs Sales Channels
7.4.2 Mental Illness Drugs Distributors
7.5 Mental Illness Drugs Customers
8 Mental Illness Drugs Market Dynamics
8.1 Mental Illness Drugs Industry Trends
8.2 Mental Illness Drugs Market Drivers
8.3 Mental Illness Drugs Market Challenges
8.4 Mental Illness Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
